Selective loss of regulatory T cells in thymomas

Myasthenia gravis (MG) is the prime autoimmune manifestation of thymomas. We investigated the generation of T cells with a regulatory phenotype (TR) in thymomas with and without associated MG. In patients with MG(+) thymomas, maturation and export of TR cells but not of other T‐cell subsets was significantly reduced. We conclude that imbalance between effector and regulatory T cells in thymomas may be involved in modulation of onset and/or severity of MG. Ann Neurol 2004;56:901–904

[1]  P. Galle,et al.  TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo. , 2004, International immunology.

[2]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[3]  H. Müller-Hermelink,et al.  Pathomechanisms of Paraneoplastic Myasthenia Gravis , 2003, Clinical & developmental immunology.

[4]  H. Müller-Hermelink,et al.  Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas. , 2002, Blood.

[5]  J. Shimizu,et al.  Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.

[6]  F. Powrie,et al.  Regulatory T cells in the control of immune pathology , 2001, Nature Immunology.

[7]  T. Laufer,et al.  Major Histocompatibility Complex Class II–Positive Cortical Epithelium Mediates the Selection of Cd4+25+ Immunoregulatory T Cells , 2001, The Journal of experimental medicine.

[8]  E. Shevach,et al.  Control of T‐cell activation by CD4+ CD25+ suppressor T cells , 2001, Immunological reviews.

[9]  D. Douek,et al.  Mature, long‐lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis , 2001, Annals of neurology.

[10]  H. Müller-Hermelink,et al.  Evidence for Distinct Mechanisms in the Shaping of the CD4 T Cell Repertoire in Histologically Distinct Myasthenia Gravis – Associated Thymomas , 2001, Developmental immunology.

[11]  L. Sobin,et al.  Histological Typing of Tumours of the Thymus , 1999, World Health Organization. International Histological Classification of Tumours.

[12]  F. Otsuka,et al.  Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. , 1999, Journal of immunology.

[13]  H. Müller-Hermelink,et al.  Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[14]  C. Pénit,et al.  Regulatory Cd4 T Cells: Expression of Il-2rα Chain, Resistance to Clonal Deletion and Il-2 Dependency , 1998 .

[15]  P. Rieckmann,et al.  Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. , 1997, Journal of immunological methods.

[16]  P. Pereira,et al.  Establishment of tissue‐specific tolerance is driven by regulatory T cells selected by thymic epithelium , 1996, European journal of immunology.

[17]  T. Wirth,et al.  Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site , 1993, Molecular and cellular biology.

[18]  J. Newsom-Davis,et al.  Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor–reactive T cells , 1990, Annals of neurology.